Initially introduced under the brand Dostinex, Cabergoline held market exclusivity in the U.S. until the mid-2000s when generic forms became available. This transition to generics expanded access, lowering costs and increasing prescriptions globally. As a cost-effective solution, generic Cabergoline is now widely used for prolactin inhibition. Dostinex’s role in establishing Cabergoline’s reputation has made it a standard treatment in prolactin management protocols, especially for conditions requiring precise hormone suppression, such as prolactinomas.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about Cabergolin 0.5 by Balkan Pharmaceuticals, consult with your doctor or healthcare professional.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.
Llewellyn, W. (2017). William Llewellyn's Anabolics.
United States: Molecular Nutrition, LLC.